Inventory / revenue moved 240 bp higher
Inventory / revenue changed +240 basis points from the comparable as-filed period.
83.09%→85.49%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →COO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net debt decreased 23.6%
Net debt changed -23.6% from the comparable as-filed period.
$2.3B→$1.8B2 prior comparisons
Gross margin moved 151 bp higher
Gross margin changed +151 basis points from the comparable as-filed period.
65.26%→66.77%2 prior comparisons
Free-cash-flow margin moved 1009 bp higher
Free-cash-flow margin changed +1009 basis points from the comparable as-filed period.
15.51%→25.60%2 prior comparisons
Operating cash-flow margin moved 739 bp higher
Operating cash-flow margin changed +739 basis points from the comparable as-filed period.
24.65%→32.05%2 prior comparisons
Debt / revenue moved 4960 bp lower
Debt / revenue changed -4960 basis points from the comparable as-filed period.
229.31%→179.71%2 prior comparisons
Debt / assets moved 453 bp lower
Debt / assets changed -453 basis points from the comparable as-filed period.
19.64%→15.12%3 prior comparisons
Capital expenditure decreased 29.1%
Capital expenditure changed -29.1% from the comparable as-filed period.
$96.9M→$68.7M2 prior comparisons
Cash & equivalents increased 23.9%
Cash & equivalents changed +23.9% from the comparable as-filed period.
$124.9M→$154.7M2 prior comparisons
Working capital / assets moved 584 bp lower
Working capital / assets changed -584 basis points from the comparable as-filed period.
9.11%→3.27%3 prior comparisons
Cash / debt moved 294 bp higher
Cash / debt changed +294 basis points from the comparable as-filed period.
5.14%→8.07%2 prior comparisons
Revenue increased 0.6%
Revenue changed +0.6% from the comparable as-filed period.
$1.1B→$1.1B2 prior comparisons
Current assets increased 6.7%
Current assets changed +6.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.1B→$2.3B4 prior comparisons
Research & development decreased 6.7%
Research & development changed -6.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$44.6M→$41.6M2 prior comparisons
Total assets increased 2.4%
Total assets changed +2.4% from the comparable as-filed period.
$12.4B→$12.7B3 prior comparisons
Selling, general & administrative decreased 4.8%
Selling, general & administrative changed -4.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$421.7M→$401.3M2 prior comparisons
Receivables / revenue moved 73 bp lower
Receivables / revenue changed -73 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
74.72%→73.99%2 prior comparisons
Inventory increased 3.5%
Inventory changed +3.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$881.0M→$911.5M4 prior comparisons
Gross profit increased 2.9%
Gross profit changed +2.9% from the comparable as-filed period.
$692.0M→$711.9M2 prior comparisons
Trade receivables decreased 0.4%
Trade receivables changed -0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$792.3M→$788.9M4 prior comparisons
R&D / revenue moved 30 bp lower
R&D / revenue changed -30 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.21%→3.90%2 prior comparisons
SBC / revenue moved 4 bp lower
SBC / revenue changed -4 basis points from the comparable as-filed period.
1.53%→1.49%2 prior comparisons
Stock-based compensation decreased 1.9%
Stock-based compensation changed -1.9% from the comparable as-filed period.
$16.2M→$15.9M2 prior comparisons
Net debt decreased 28.5%
Net debt changed -28.5% from the comparable as-filed period.
$2.4B→$1.7B2 prior comparisons
Operating income changed across a sign change
Operating income changed -116.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$184.8M→-$31.0M2 prior comparisons
Receivables / revenue moved 309 bp lower
Receivables / revenue changed -309 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
77.91%→74.82%2 prior comparisons
Free-cash-flow margin moved 711 bp higher
Free-cash-flow margin changed +711 basis points from the comparable as-filed period.
1.81%→8.91%2 prior comparisons
Debt / assets moved 543 bp lower
Debt / assets changed -543 basis points from the comparable as-filed period.
20.35%→14.91%3 prior comparisons
Debt / revenue moved 7988 bp lower
Debt / revenue changed -7988 basis points from the comparable as-filed period.
251.98%→172.10%2 prior comparisons
Operating cash-flow margin moved 730 bp higher
Operating cash-flow margin changed +730 basis points from the comparable as-filed period.
9.60%→16.90%2 prior comparisons
Revenue increased 7.9%
Revenue changed +7.9% from the comparable as-filed period.
$1.0B→$1.1B2 prior comparisons
Shares outstanding decreased 2.2%
Shares outstanding changed -2.2% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
199,512,504→195,030,6308 prior comparisons
Working capital / assets moved 500 bp lower
Working capital / assets changed -500 basis points from the comparable as-filed period.
8.97%→3.97%3 prior comparisons
Cash / debt moved 286 bp higher
Cash / debt changed +286 basis points from the comparable as-filed period.
4.60%→7.46%2 prior comparisons
Cash & equivalents increased 19.4%
Cash & equivalents changed +19.4% from the comparable as-filed period.
$116.2M→$138.8M2 prior comparisons
Current assets increased 8.2%
Current assets changed +8.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.1B→$2.3B4 prior comparisons
Stock-based compensation decreased 23.6%
Stock-based compensation changed -23.6% from the comparable as-filed period.
$20.3M→$15.5M2 prior comparisons
Gross margin moved 24 bp higher
Gross margin changed +24 basis points from the comparable as-filed period.
67.75%→68.00%2 prior comparisons
Capex / revenue moved 20 bp higher
Capex / revenue changed +20 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
7.79%→7.99%2 prior comparisons
Gross profit increased 8.3%
Gross profit changed +8.3% from the comparable as-filed period.
$679.1M→$735.4M2 prior comparisons
Research & development decreased 6.6%
Research & development changed -6.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$45.5M→$42.5M2 prior comparisons
SBC / revenue moved 59 bp lower
SBC / revenue changed -59 basis points from the comparable as-filed period.
2.03%→1.43%2 prior comparisons
Total assets increased 0.6%
Total assets changed +0.6% from the comparable as-filed period.
$12.4B→$12.5B3 prior comparisons
R&D / revenue moved 61 bp lower
R&D / revenue changed -61 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.54%→3.93%2 prior comparisons
Trade receivables increased 3.6%
Trade receivables changed +3.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$780.9M→$809.2M4 prior comparisons
Capital expenditure increased 10.6%
Capital expenditure changed +10.6% from the comparable as-filed period.
$78.1M→$86.4M3 prior comparisons
Inventory increased 1.8%
Inventory changed +1.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$880.3M→$896.4M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.